Retinal changes and cardiac biomarker assessment in relation to chronic kidney disease: a single centre study

Ruslinda Mustafar1, Khairun Amalin Mohd Hishamuddin2, Rozita Mohd1

  • 1Department of Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.

BMC Nephrology
|November 14, 2023
PubMed

Insights

Chronic kidney disease (CKD) in Malaysia is rising. Retinal vessel changes and cardiac biomarkers like hs-CRP correlate with CKD progression, offering potential non-invasive assessment tools. Macula volume may indicate cardiovascular risk in CKD patients.

Area of Science:

  • Ophthalmology and Nephrology
  • Biomarker Discovery
  • Cardiovascular Risk Stratification

Background:

  • Rising prevalence of chronic kidney disease (CKD) in Malaysia necessitates early detection to mitigate cardiovascular (CV) risks, a leading cause of death in end-stage renal disease (ESRD).
  • Retinal changes serve as indicators of CKD, while cardiac biomarkers aid in assessing cardiovascular risk.
  • This study investigates the relationship between retinal changes, cardiac biomarkers, and CKD.

Purpose of the Study:

  • To explore the correlation between specific retinal imaging parameters and cardiac biomarkers in patients with varying stages of chronic kidney disease (CKD).
  • To evaluate the potential of these parameters as non-invasive markers for CKD assessment and cardiovascular risk stratification.

Main Methods:

  • A single-centre, cross-sectional study involving 84 patients with CKD stages 3-5 (non-dialysis).
  • Fundus photography was used to analyze retinal vessel calibre (CRVE, CRAE) and tortuosity.
  • Optical coherence tomography measured macular volume, while blood samples assessed hs-CRP and ADMA levels.

Main Results:

  • Retinal vessel tortuosity and central retinal venular equivalent (CRVE) showed significant correlations with estimated glomerular filtration rate (eGFR) and proteinuria.
  • High-sensitivity C-reactive protein (hs-CRP) levels correlated negatively with eGFR and positively with proteinuria.
  • Diabetic patients exhibited higher CRVE, while a history of ischemic heart disease was linked to smaller macula volume. Age, male gender, HbA1c, and hs-CRP influenced retinal parameters.

Conclusions:

  • eGFR is a significant factor influencing retinal vessel tortuosity, CRVE, and hs-CRP, suggesting their utility as non-invasive CKD assessment tools.
  • Macula volume appears to be the primary parameter associated with cardiovascular risk within the CKD population.
  • Further research is warranted to validate these findings and their clinical applicability in managing CKD patients.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
17
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
11
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
13
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
9
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
101